Simulation of Facial Soft Tissue in Orthognathic Surgery
Launched by CENTRE HOSPITALIER ANNECY GENEVOIS · Feb 11, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help patients better understand how they might look after undergoing orthognathic surgery, which is a procedure to correct jaw and facial bone problems. The researchers want to see if a computer program can accurately predict the changes to a patient's face after surgery. This program uses advanced imaging technology to create a 3D model that simulates what the surgical results will likely look like. By comparing these simulations to actual results from scans taken six months after the surgery, the team hopes to provide patients with a clearer idea of what to expect in terms of their appearance post-surgery.
To participate in the study, you need to be over 18 years old and scheduled for certain types of jaw surgery. You should also be able to understand French and give your consent to be part of the study. Participants will undergo their usual surgical procedures and will receive a pre- and post-operative scan to help evaluate the accuracy of the program’s predictions. This study is not yet recruiting participants, but it's a great opportunity for those who want to have a better understanding of their surgical outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient over 18 ;
- • Patients who have been informed of the study and who have freely given their informed consent to participate in the study;
- • Patient undergoing isolated mandibular or maxillary orthognathic surgery, or maxillo-mandibular surgery with or without genioplasty for any indication (occlusal disorder, sleep apnoea syndrome, functional joint disorder, etc.);
- • Patient covered by a French social security scheme
- Exclusion Criteria:
- • Patient with maxillary disjunction ;
- • Patients with facial malformations;
- • Pregnant or breast-feeding patient;
- • Patient under guardianship;
- • Patients who do not understand French;
- • Patients under court protection
- • No pre- or postoperative CT scan or CT scan that cannot be used
- • Surgery, trauma, progressive infection or cosmetic injection on the face after orthognathic surgery and before the postoperative scan
About Centre Hospitalier Annecy Genevois
The Centre Hospitalier Annecy Genevois (CHAG) is a leading healthcare institution located in the Auvergne-Rhône-Alpes region of France, renowned for its commitment to advancing medical research and enhancing patient care. As a clinical trial sponsor, CHAG leverages its multidisciplinary expertise and state-of-the-art facilities to conduct innovative research across various therapeutic areas. The center prioritizes collaboration with academic institutions and industry partners to facilitate the development of new treatments and improve clinical outcomes. With a focus on ethical practices and patient safety, CHAG is dedicated to contributing valuable insights to the global medical community through its rigorous clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Georges BETTEGA
Principal Investigator
Centre Hospitalier Annecy Genevois
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported